TOFASYKE-XR 11 TABLETS
TOFASYKE-XR 11 TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | TOFASYKE-XR 11 Tablets |
| Form | Extended-Release Tablets |
| Key Ingredient | Tofacitinib 11 mg |
| Therapeutic Class | Disease-Modifying Anti-Rheumatic Drug (DMARD) / JAK Inhibitor |
| Core Benefits | Reduces joint inflammation, stiffness, and pain in autoimmune conditions |
| Mechanism of Action | Inhibits Janus Kinase (JAK) pathways, reducing pro-inflammatory cytokines |
| Support Areas | Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis |
| Recommended Usage | Once daily with or without food, as prescribed by a specialist |
Composition: Tofacitinib 11mg ER Tablets Packing: 10X10 Alu Alu
Description : TOFASYKE-XR 11 Tablets contain Tofacitinib 11 mg (Extended Release), a JAK inhibitor used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by modulating immune responses and reducing inflammation at the cellular level. The XR (Extended Release) formulation provides once-daily dosing, ensuring sustained therapeutic action throughout the day. TOFASYKE-XR 11 is ideal for patients needing long-term inflammation control with improved convenience. Always use rheumatologist or specialist supervision due to immunomodulatory effects.